ARCHIVES

NCI Management Director Leaving For Case Institute.

This article is from The Cancer Letter archive.

Vol. 27 No. 37 | October 12, 2001

Download PDF Visit The Full Archive

Related Articles

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976

NCI Proposes Moving Organ Systems coordinating Center Activities In House, Dispersing Grants

October 16, 1987

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008